Data breach in S.C. affects 228K Medicaid beneficiaries

Jeff Byers | | Health Exec | Policy & Regulations
Cybersecurity - 140.80 Kb
The South Carolina Department of Health and Human Services (SCDHHS) discovered this month that a Medicaid employee inappropriately transferred personal information for 228,435 Medicaid beneficiaries to their personal email account, constituting a violation of agency policy.

In addition to terminating the employee, the department immediately contacted the S.C. Law Enforcement Division to investigate the incident and also informed other state and federal agencies.

More than 90 percent of the affected beneficiaries live in six counties: Allendale, Bamberg, Barnwell, Lexington, Orangeburg and Richland. For affected beneficiaries, SCDHHS is offering free services to protect them from possible identity theft. Affected beneficiaries will receive a letter from SCDHHS with further instructions. 

SCDHHS added this incident does not involve medical information and does not affect any current beneficiaries’ Medicaid eligibility status.

Jeff Byers

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.